Pharma BD Deal Intelligence

Genzyme Corporation / ILEX Oncology Inc.

2004 · Acquisition/Merger · $1.0B · Complete

Stock-for-stock; San Antonio TX; Campath/alemtuzumab; FTC required Schering AG divestiture for SOT use

Key facts

• Announced Feb 26, 2004
• Deal value $1.0B
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals